Kimball Electronics (KE) Q1 2027 Earnings Call Transcript

Kimball Electronics (KE) reported Q1 2027 net sales of $391M, up 7% YoY, with medical sales growing 14%. Adjusted net income fell to $6.1M from $12.3M YoY. Full-year sales guidance is expected at the high end of the range, driven by medical strength and the HealthWet acquisition. Inventory increased by $40M, and the tax rate spiked to 66.1% due to acquisition-related withholding taxes.

Kimball Electronics reported 3Q 2026 revenue of $390.8M, up 7% YoY, but net income fell 73.8% to $2.64M due to higher expenses. Medical and Helvoet sales drove growth, while Indianapolis facility costs impacted margins. Open orders rose 16% to $690M.

Kimball Solutions (KE) reported Q3 CY2026 revenue of $390.8M, up 6.9% YoY, beating estimates. However, adjusted EPS of $0.25 missed expectations by 37%. The company expects full-year revenue of $1.55B, in line with analyst forecasts. Shares dropped 9% post-results.

Kimball Electronics (KE) reported Q1 EPS of $0.25, missing estimates by $0.13, but revenue of $390.8M exceeded expectations. The company forecasts FY 2027 revenue between $1.54B-$1.56B. KE's stock is down 1.03% over 3 months and 14.88% over 12 months.

Kimball Electronics, Inc. (KE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 KIMBALL ELECTRONICS REPORTS Q1 RESULTS HIGHLIGHTED BY THE RETURN TO TOP-LINE GROWTH; COMPANY REITERATES GUIDANCE FOR FISCAL 2027 WITH SALES EXPECTED AT THE HIGH END OF THE RANGE JASPER, Ind., November 4, 2026 -- (BUSINESS WIRE) -- Kimball Electronics, Inc. (Nasdaq: K

Kimball Electronics (KE) reported Q1 FY2027 sales growth and reiterated its FY2027 sales guidance of $1.535B–$1.560B, expected at the high end. The company did not provide a prior-period comparison for context.